COMMUNIQUÉS West-GlobeNewswire

Novartis réalise une solide croissance au deuxième trimestre et poursuit sa transformation en une entreprise axée sur les médicaments
18/07/2018
Hausse du chiffre d'affaires net de 5% (tcc[1], +7% USD), stimulée principalement par: Cosentyx, qui a progressé à USD 701 millions, (+40% tcc), enregistrant une forte croissance dans toutes ses indications aux Etats- [...]
Rubius Therapeutics Announces Pricing of Initial Public Offering
18/07/2018
CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering
18/07/2018
SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Kane Biotech Announces Closing of Loan Transaction
18/07/2018
WINNIPEG, Manitoba, July 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced that it has received a loan (the “Loan”) in the amount of $500,000 [...]
Actinium Forms Nuclear Medicine Focused Advisory Board to Facilitate Pipeline Clinical Development and Iomab-B Commercial Planning
17/07/2018
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), today announced that it has appointed the members of its Nuclear Medicine Clinical Advisory [...]
CorVel Announces Quarterly Earnings Release Webcast
17/07/2018
IRVINE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Gordon Clemons, Chief Executive Officer Michael Combs, President Date: Tuesday, July 31 st , 2018 Time: 11:30 am EST. [...]
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018
17/07/2018
LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the [...]
Imagin Medical Reports Research Study Progress
17/07/2018
VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10- [...]
Cara Therapeutics Announces Proposed Offering of Common Stock
17/07/2018
STAMFORD, Conn., July 17, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
AC Immune Announces Offerings and Issuance of up to 10 Million Common Shares
17/07/2018
Lausanne, Switzerland, July 17, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced that it is commencing offerings of up to [...]
ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call
17/07/2018
SAN CLEMENTE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors
17/07/2018
WALTHAM, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Veritas Pharma Signs IP Agreement with UK’s First Medicinal Cannabis Investment Fund
17/07/2018
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that it has signed an Intellectual Property [...]
CytomX Therapeutics Announces Closing of Public Offering of Common Stock
17/07/2018
SOUTH SAN FRANCISCO, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Orion Biotechnology Awarded a $2M Grant from National Center for Research and Development to Fund Further Development of its HIV Microbicide
17/07/2018
OTTAWA, July 17, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its European subsidiary, Orion Biotechnology Polska Sp. z o.o., was awarded a [...]
bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung
17/07/2018
SAN ANTONIO, July 17, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced it has commenced its test validation trial for CyPath® Lung, an advanced flow [...]
Tabula Rasa HealthCare Hosts Inaugural PACE Executive Director Advisory Meeting
17/07/2018
Goal: to confirm client priorities and perspectives related to future healthcare and changes for PACE MOORESTOWN, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC) held its annual [...]
Matrix Medical Network announces the appointment of Ian Worden as Vice President, Product & Marketing
17/07/2018
SCOTTSDALE, Ariz., July 17, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population health provider of in-home and mobile health services, has announced that Ian Worden has joined the company as [...]
Virbac : Revenue grew by +4.3% at constant exchange rates in the second quarter of 2018
17/07/2018
Key figures Net revenue 1 st half 2018- Provisional €429.7 million Total growth -1.8% Growth at constant exchange rates 1 +3.8% Growth at constant scope 1 +3.8% of which companion animals +5.0% (+8.5% excl. USA) food [...]

Pages